Ana M.D. Carneiro

2.3k total citations
27 papers, 1.7k citations indexed

About

Ana M.D. Carneiro is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Ana M.D. Carneiro has authored 27 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 4 papers in Cognitive Neuroscience. Recurrent topics in Ana M.D. Carneiro's work include Receptor Mechanisms and Signaling (16 papers), Neurotransmitter Receptor Influence on Behavior (14 papers) and Neuroscience and Neuropharmacology Research (9 papers). Ana M.D. Carneiro is often cited by papers focused on Receptor Mechanisms and Signaling (16 papers), Neurotransmitter Receptor Influence on Behavior (14 papers) and Neuroscience and Neuropharmacology Research (9 papers). Ana M.D. Carneiro collaborates with scholars based in United States, China and France. Ana M.D. Carneiro's co-authors include Randy Blakely, Gonzalo E. Torres, Marc G. Caron, Chong-Bin Zhu, Jennifer A. Steiner, Edwin H. Cook, Wolfgang R. Dostmann, Dennis L. Murphy, William A. Hewlett and Chiara Fiorentini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Ana M.D. Carneiro

27 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana M.D. Carneiro United States	18	754	748	345	251	244	27	1.7k
Minae Niwa Japan	27	862 1.1×	893 1.2×	231 0.7×	315 1.3×	213 0.9×	56	2.0k
Samantha J. Fung Australia	22	693 0.9×	847 1.1×	360 1.0×	485 1.9×	228 0.9×	27	1.9k
Hubert Fiumelli Switzerland	23	966 1.3×	1.3k 1.7×	308 0.9×	189 0.8×	122 0.5×	33	2.2k
Juan E. Belforte Argentina	18	601 0.8×	1.1k 1.4×	536 1.6×	198 0.8×	157 0.6×	26	1.7k
Koko Ishizuka United States	21	1.4k 1.8×	714 1.0×	247 0.7×	330 1.3×	431 1.8×	59	2.5k
Hanna Jaaro-Peled United States	22	1.2k 1.6×	867 1.2×	327 0.9×	353 1.4×	339 1.4×	36	2.1k
Michelle Potter United States	15	667 0.9×	450 0.6×	246 0.7×	447 1.8×	176 0.7×	22	2.0k
Shuji Iritani Japan	25	817 1.1×	734 1.0×	436 1.3×	208 0.8×	220 0.9×	102	2.6k
Anjali M. Rajadhyaksha United States	28	1.1k 1.5×	1.2k 1.6×	371 1.1×	113 0.5×	163 0.7×	72	2.0k
Rochelle M. Hines United States	21	982 1.3×	1.2k 1.6×	332 1.0×	144 0.6×	260 1.1×	35	2.2k

Countries citing papers authored by Ana M.D. Carneiro

Since Specialization

Citations

This map shows the geographic impact of Ana M.D. Carneiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana M.D. Carneiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana M.D. Carneiro more than expected).

Fields of papers citing papers by Ana M.D. Carneiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana M.D. Carneiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana M.D. Carneiro. The network helps show where Ana M.D. Carneiro may publish in the future.

Co-authorship network of co-authors of Ana M.D. Carneiro

This figure shows the co-authorship network connecting the top 25 collaborators of Ana M.D. Carneiro. A scholar is included among the top collaborators of Ana M.D. Carneiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana M.D. Carneiro. Ana M.D. Carneiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Hope, Nir Pillar, Boaz Barak, et al.. (2023). Impaired myelin ultrastructure is reversed by citalopram treatment in a mouse model for major depressive disorder. Journal of Psychiatric Research. 166. 100–114. 3 indexed citations

Pan, Hope, et al.. (2019). Integrin αVβ3 Function Influences Citalopram Immobility Behavior in the Tail Suspension Test. Frontiers in Neuroscience. 13. 70–70. 4 indexed citations

Yang, Fan, Zhilu Chen, Janak L. Pathak, Ana M.D. Carneiro, & Chang Y. Chung. (2018). Differential Regulation of Adhesion and Phagocytosis of Resting and Activated Microglia by Dopamine. Frontiers in Cellular Neuroscience. 12. 309–309. 49 indexed citations

Dohn, Michael R., Lisa Bastarache, Tammy Jessen, et al.. (2017). The Gain-of-Function Integrin β3 Pro33 Variant Alters the Serotonin System in the Mouse Brain. Journal of Neuroscience. 37(46). 11271–11284. 21 indexed citations

Jessen, Tammy, et al.. (2015). Integrin β3 Haploinsufficiency Modulates Serotonin Transport and Antidepressant-Sensitive Behavior in Mice. Neuropsychopharmacology. 40(8). 2015–2024. 24 indexed citations

Jessen, Tammy, et al.. (2015). Mice lacking integrin β3 expression exhibit altered response to chronic stress. Neurobiology of Stress. 2. 51–58. 13 indexed citations

Carneiro, Ana M.D., Qiao Han, David Airey, et al.. (2014). Quantitative trait loci mapping and gene network analysis implicate protocadherin‐15 as a determinant of brain serotonin transporter expression. Genes Brain & Behavior. 13(3). 261–275. 9 indexed citations

Jessen, Tammy, et al.. (2014). Pro32Pro33 Mutations in the Integrin β3 PSI Domain Result in αIIbβ3 Priming and Enhanced Adhesion: Reversal of the Hypercoagulability Phenotype by the Src Inhibitor SKI-606. Molecular Pharmacology. 85(6). 921–931. 6 indexed citations

Carneiro, Ana M.D., David Airey, Elaine Sanders‐Bush, et al.. (2013). Evaluation of heritable determinants of blood and brain serotonin homeostasis using recombinant inbred mice. Genes Brain & Behavior. 13(3). 247–260. 16 indexed citations

10.

Veenstra‐VanderWeele, Jeremy, Christopher L. Muller, Hideki Iwamoto, et al.. (2012). Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proceedings of the National Academy of Sciences. 109(14). 5469–5474. 246 indexed citations

11.

Chang, Jennifer C., Ian D. Tomlinson, Michael R. Warnement, et al.. (2012). Single Molecule Analysis of Serotonin Transporter Regulation Using Antagonist-Conjugated Quantum Dots Reveals Restricted, p38 MAPK-Dependent Mobilization Underlying Uptake Activation. Journal of Neuroscience. 32(26). 8919–8929. 64 indexed citations

12.

Muller, Christopher L., et al.. (2011). Absence of preference for social novelty and increased grooming in integrin β3 knockout mice: Initial studies and future directions. Autism Research. 4(1). 57–67. 85 indexed citations

13.

Carneiro, Ana M.D., David Airey, B. J. Thompson, et al.. (2009). Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes. Proceedings of the National Academy of Sciences. 106(6). 2047–2052. 67 indexed citations

14.

Carneiro, Ana M.D.. (2009). The emerging role of integrins in neuropsychiatric disorders. Neuropsychopharmacology. 35(1). 338–339. 4 indexed citations

15.

Steiner, Jennifer A., Ana M.D. Carneiro, & Randy Blakely. (2008). Going with the Flow: Trafficking‐Dependent and ‐Independent Regulation of Serotonin Transport. Traffic. 9(9). 1393–1402. 106 indexed citations

16.

Carneiro, Ana M.D., Edwin H. Cook, Dennis L. Murphy, & Randy Blakely. (2008). Interactions between integrin αIIbβ3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. Journal of Clinical Investigation. 118(4). 1544–1552. 138 indexed citations

17.

Carneiro, Ana M.D. & Randy Blakely. (2006). Serotonin-, Protein Kinase C-, and Hic-5-associated Redistribution of the Platelet Serotonin Transporter. Journal of Biological Chemistry. 281(34). 24769–24780. 83 indexed citations

18.

Zhu, Chong-Bin, Ana M.D. Carneiro, Wolfgang R. Dostmann, William A. Hewlett, & Randy Blakely. (2005). p38 MAPK Activation Elevates Serotonin Transport Activity via a Trafficking-independent, Protein Phosphatase 2A-dependent Process. Journal of Biological Chemistry. 280(16). 15649–15658. 171 indexed citations

19.

Torres, Gonzalo E., et al.. (2003). Oligomerization and Trafficking of the Human Dopamine Transporter. Journal of Biological Chemistry. 278(4). 2731–2739. 223 indexed citations

20.

Carneiro, Ana M.D., Susan Ingram, Jean‐Martin Beaulieu, et al.. (2002). The Multiple LIM Domain-Containing Adaptor Protein Hic-5 Synaptically Colocalizes and Interacts with the Dopamine Transporter. Journal of Neuroscience. 22(16). 7045–7054. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact